“…There is a growing consensus that specific HLA alleles and heterozygosity at HLA class I loci can collectively exert a strong impact on disease progression in human immunodeficiency virus type 1 (HIV-1) infection (6,8,21,22,30,31,35,41,62,63); much of the effect appears to correlate with cytotoxic T-lymphocyte (CTL) responses directly restricted by class I allelic products in both humans (3,16,18,34,56) and chimpanzees (2). HLA markers associated with delayed HIV-1 disease progression may present epitopes found more frequently in various HIV-1 proteins (45), and the two most prominent alleles (B*27 and B*57) have been found experimentally to induce immunodominant CTL responses to conserved HIV-1 epitopes (15,19,20,44).…”